Our Executive Director, Lauren Leiman, will moderate an insightful panel discussion titled “Improving Cancer Care Requires Payers at the Table” at the 32nd Precision Med TRI-CON in San Diego, California, on March 12, 2025. The panel will feature distinguished leaders Robert Dumanois (Thermo Fisher) and Suzanne Belinson (Tempus), offering a dynamic dialogue on payer involvement in advancing cancer care.

Following the panel, Lauren will deliver a presentation titled “Analytical Validation Continued: BLOODPAC’s Generic MRD Protocol,” highlighting the transformative impact of tumor-agnostic MRD analytical validation protocols on the patient journey.